Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Regulatory News

Date Source Headline
5th Feb 2016 7:00 am RNS Proposed Placing and Subscription
21st Jan 2016 5:33 pm RNS Holding(s) in Company
15th Dec 2015 7:00 am RNS ImmuPharma & Simbec-Orion - Investigators Meeting
7th Dec 2015 7:00 am RNS Update on the progress of Lupuzor
30th Nov 2015 11:55 am RNS Holding(s) in Company
4th Nov 2015 8:26 am RNS Lupuzor Phase III Pivotal Trial Update
4th Nov 2015 7:00 am RNS Lupuzor Phase III Pivotal Trial Update
23rd Oct 2015 7:00 am RNS Directorate Change
30th Sep 2015 7:05 am RNS Directorate Change
30th Sep 2015 7:00 am RNS Interim Results
29th Jul 2015 7:00 am RNS Richard Warr
27th Jul 2015 7:00 am RNS TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR
25th Jun 2015 7:00 am RNS Lupuzor's Founder Dr Slyviane Muller Awarded Medal
29th May 2015 12:50 pm RNS Result of AGM
6th May 2015 3:44 pm RNS Annual Report & Accounts
6th May 2015 7:02 am RNS Interim Board Change
30th Apr 2015 7:05 am RNS Directorate Change
30th Apr 2015 7:00 am RNS Preliminary Results
11th Feb 2015 12:02 pm RNS CANCER UPDATE: IPP-204106
27th Jan 2015 7:00 am RNS Enterprise Investment Scheme Status
22nd Jan 2015 7:00 am RNS Collaboration Agreement with Simbec-Orion
30th Oct 2014 11:10 am RNS Holding(s) in Company
28th Oct 2014 7:00 am RNS Holding(s) in Company
21st Oct 2014 7:00 am RNS Additional Listing - Conditional Placing
20th Oct 2014 7:00 am RNS ImmuPharma awarded EUR400,000 Grant
30th Sep 2014 7:05 am RNS Half Yearly Report
30th Sep 2014 7:00 am RNS LupuzorT Gears Up To Start Pivotal Phase III trial
27th Jun 2014 1:11 pm RNS Result of AGM
27th Jun 2014 7:00 am RNS Access to pioneering research in Bordeaux France
16th Jun 2014 7:00 am RNS NEW NUCANT PATENTS
23rd May 2014 7:00 am RNS Annual Financial Report
21st May 2014 7:00 am RNS Preliminary Results
6th May 2014 12:47 pm RNS Dr. Sylviane Muller - Presentation Abstract
23rd Apr 2014 7:00 am RNS Dr. S Muller, founder of Lupuzor presentation.
11th Apr 2014 7:00 am RNS ImmuPharma Sponsors the 2014 European Lupus Confer
14th Oct 2013 7:00 am RNS Additional Listing
27th Sep 2013 7:00 am RNS Half Yearly Report
13th Aug 2013 7:00 am RNS UPDATE CANCER PROGRAMME IPP-204106
31st Jul 2013 7:00 am RNS FDA GRANTS IMMUPHARMA AMENDED SPA
8th Jul 2013 8:00 am RNS IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERS
FTSE 100 Latest
Value10,600.53
Change-2.95